Skip to main content
Caplight Logo









Panluminate, Inc.

Panluminate, Inc.

Private
New Haven, ConnecticutHealthcare & Life Scienceshttps://www.panluminate.com/

Last Round

Grant

Aug 1, 2026

Total Funding Raised

$1.22M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Panluminate, Inc. is a neurotech company that develops infrastructure for whole-brain connectomics, including tissue-staining chemistry, light-sheet microscopy, and AI-powered analysis tools for neuroscience and drug development.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Imaging, Biotech Equipment, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting, Subscription SaaS

AI Layer

Application

Keywords

connectomicsspatial biologyexpansion microscopyExMneurotechspatial proteomicslight sheet microscopyneuron tracingbiological AICNS drug developmentCRO servicescontract research organizationnanoscale imagingbio-imagingdigital pathologylab automation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Panluminate, Inc. Comparables

Compare Panluminate, Inc. with similar companies based on industry and business-model similarity.

Panluminate, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
LifeCanvas Technologies
85%
Alpenglow Biosciences
81%
Magnify Biosciences
81%

Panluminate, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantAug 1, 2026
GrantAug 1, 2026
GrantSep 10, 2024

Key People

Founding team and executive leadership

Martin Leach

Chief Advisor to Chief Executive Officer

Executive Team

Ons M'Saad

Co-founder & CEO

Founding Team

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    $455K grant from the National Institute of Mental Health.

  • Aug 1, 2026

    $355K grant received from National Institute of Diabetes and Digestive and Kidney Diseases.

Panluminate, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Panluminate, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Panluminate, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNew Haven, Connecticut
Employee Range19
Year Founded2021
Last FundingAug 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?